top
Search terms
Results 1 - 10 of 23 - ordered by :
Pages: 1 2 3
Epeuropace

Introduction Heart failure is a common clinical syndrome affecting 2.5% adults in developed countries and the cost of heart failure exceeds $33 billion per year.1 It substantially impairs quality of ...

Europace, CLINICAL RESEARCH, Shaojie Chen, Yuehui Yin, Mitchell W. Krucoff

Date : 01/11/2012 Item size : 220613 bytes
Epeuropace

Patients with moderate to severe heart failure who meet the criteria for implantation of a cardiac resynchronization therapy (CRT) device and/or an implantable defibrillator (ICD) carry a startling ...

Europace, Editorial, Frieder Braunschweig

Date : 01/05/2010 Item size : 141448 bytes
Epeuropace

The efficacy of CRT-D relative to optimal medical therapy is supported by direct evidence of survival benefit from a randomized control trial (COMPANION) as well as a network meta-analysis ...

Europace, Letter to the Editor, Simon K.H. Lam, Andrew Owen

Date : 01/04/2008 Item size : 100670 bytes
Epeuropace

The Cardiostim team and Prof. Aladar Ronaszeki organised an educational meeting in Budapest from April 6 to 8 entitled Pacing and Haemodynamics: Art of Timing This European congress has been an ...

Europace, Regular Article, Philippe Ritter

Date : 01/05/2005 Item size : 120918 bytes
Epeuropace

Background: Recent studies have shown that cardiac resynchronisation therapy (CRT) leads to an improvement in symptoms, exercise capacity and quality of life in patients with heart failure. Methods: ...

Europace, CARDIOSTIM, SEVILLE

Date : 01/10/2003 Item size : 111126 bytes
Epeuropace

Clémenty (3-2) shows a reduction in the drug regimen, correlated with the improvement in the clinical status of his patient population, whereas Senni (3-3) reports the preliminary results of the ...

Europace, CARDIOSTIM, SEVILLE, Philippe Ritter

Date : 01/10/2003 Item size : 99763 bytes
Epeuropace

ELECTRICAL CHARACTERISTICS, DISLOCATION RATE AND MORTALITY Yves Vandekerckhove, AZ St. Jan, Belgium; Arjan Van den Bos, Amphia Ziekenhuis, The Netherlands; Juri Voitk, General Hospital Tallinn, ...

Europace, CARDIOSTIM, SEVILLE

Date : 01/10/2003 Item size : 126600 bytes
Epeuropace

Method: Ambulatory patients (pts). aged 4375 (14 females), who presented NYHA class IIIII congestive heart failure and had been on stable and assumedly optimal therapy with a diuretic (four pts.) or ...

Europace, CARDIOSTIM, SEVILLE

Date : 01/10/2003 Item size : 127336 bytes
Epeuropace

Abstract Background Reduced cognitive performance and high prevalence of depression have been reported in patients with congestive heart failure (CHF) and severe left ventricular dysfunction. Heart ...

Europace, Pacing and resynchronization therapy, David Duncker, Katrin Friedel, Thorben König, Hendrik Schreyer, Ulrich Lüsebrink, Mareke Duncker, Hanno Oswald, Gunnar Klein, Ajmal Gardiwal

Date : 01/09/2015
Epeuropace

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality Abstract Aims Comorbidity, such as myocardial ...

Europace, CLINICAL RESEARCH, Dominic A.M.J. Theuns, Beat A. Schaer, Osama I.I. Soliman, David Altmann, Christian Sticherling, Marcel L. Geleijnse, Stefan Osswald, Luc Jordaens

Date : 01/01/2011